• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Trending
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

divestment

musical chairs
MedTech

Teleflex buys Biotronic’s vascular catalog, plans company split

Teleflex announced plans to split into two companies—and is setting up one scion with cath lab assets from Biotronik.
Conor Hale Feb 27, 2025 11:00am
BD Becton Dickinson Building

BD bids farewell to its diagnostic, bioscience divisions

Feb 6, 2025 1:10pm
dictionary definition of divest

RFK Jr. will divest interests in biotechs if HHS role confirmed

Jan 22, 2025 1:37pm
visual of money going into a piggy bank

Surgalign sells spinal implant product lines for $17M

Mar 2, 2023 12:58pm
cancer cell lymphocytes T cells cancer

Exact Sciences sells Oncotype prostate cancer test for $30M

Aug 3, 2022 11:37am
Blood sample microscope study clinical trial lab research

PerkinElmer to sell off 3 units for $2.45B, reclaim Dx focus

Aug 2, 2022 12:57pm

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings